THE ROLE OF BIOMARKERS AND CLINICAL AND ANAMNESTIC FACTORS IN PRE-ECLAMPSIA

Авторы

  • Dilrukh Shavkatillayeva Clinical residents of the Department of Obstetrics and Gynecology No. 2 of Samarkand State Medical University Автор
  • Nafosat Khurramova Clinical residents of the Department of Obstetrics and Gynecology No. 2 of Samarkand State Medical University Автор
  • N.R. Nasimova Scientific supervisor: DcS Автор

Ключевые слова:

pre-eclampsia, pregnancy, biomarkers, eclampsia, hypertensive conditions..

Аннотация

Preeclampsia is one of the most dangerous complications of pregnancy, being a significant cause of maternal and perinatal mortality. Modern methods of predicting this condition are based on the analysis of clinical and anamnestic data, as well as on the assessment of specific biomarkers. Further studies of pathogenesis and the development of optimal prognostic algorithms will help to improve the accuracy of identifying high-risk groups and make screening more effective and accessible. This paper analyzes the scientific literature on the problem of early diagnosis of preeclampsia. The key risk factors influencing the development of pathology, and modern hypotheses about the mechanisms of its occurrence are considered. Particular attention is paid to the role of biochemical markers in predicting the disease, as well as the most promising predictors and their combinations that can improve the quality of early detection of high-risk patients.

Библиографические ссылки

Bartsch E., Medcalf K. E., Park A. L., Ray J. G. High Risk of Preeclampsia Identification Group.Clinical risk factors for preeclampsia determined in early pregnancy: systematic review and meta-analysis of large cohortstudies. BMJ. 2016;353. doi:10.1136/ bmj.i1753.

Jinqqi Q., Bingbing W., Xiuying C., Wei W., Xudong Y. Diagnostic biomolecules and combination therapy for pre-eclampsia. Reprod Biol Endocrinol. 2022;20(1):136. doi:10.1186/s12958-022-01003-3.

Kh K. Z., Kh Z. Z. FEATURES OF HEART RHYTHM DISORDERS AT DIFFERENT STAGES OF GESTATION //Talqin va tadqiqotlar ilmiy-uslubiy jurnali. – 2024. – Т. 2. – №. 54. – С. 272-277.

Abdumuminovna S. Z., Asliddinovich S. S., Khamzaevna K. Z. MODERN ASPECTS OF HYPERPLASTIC PRO //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 788-791.

Cnattingius S., Reilly M., Pawitan Y., Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A. 2004;130A:365-371. doi:10.1002/ajmg.a.30257.

. Christopher W. I., Rachel S., Indranee R., Alan T. N., Suzanne O.: Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;0ct 6;76(14):1690-1702. doi:10.1016/j.jacc.2020.08.014.

Khudoyarova D. R., Kh K. Z., Kh Z. Z. ARRHYTHMIAS IN PREGNANCY: TACTICS OF PATIENT MANAGEMENT //Eurasian Journal of Medical and Natural Sciences. – 2024. – Т. 4. – №. 9. – С. 119-123.

Кобилова З. Х., Худоярова Д. Р. СОВРЕМЕННЫЙ ВЗГЛЯД НА ИДИОПАТИЧЕСКИЕ НАРУШЕНИЯ РИТМА СЕРДЦА В РАЗЛИЧНЫЕ СРОКИ ГЕСТАЦИИ //Eurasian Journal of Medical and Natural Sciences. – 2024. – Т. 5. – №. 1. – С. 50-55.

Shopulotova Z., Kobilova Z., Bazarova F. TREATMENT OF COMPLICATED GESTATIONAL PYELONEPHRITIS IN PREGNANTS //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 630-634.

Shopulotova Z., Kobilova Z., Shopulotov S. URINATION DISORDERS IN PREGNANT WOMEN //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 774-777.

Saito S., Shiozaki A., Nakashima A., Sakai M., Sasaki Y.The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28:192-209. doi: 10.1016/j.mam.2007.02.006.

Rana S., Granger J., Granger J. P., Karumanchi S. A. Preeclampsia: pathophysiology, challenges and perspecticves. Circ Res. 2019;124(7):1094-1112. doi: 10.1161/CIRCRESAHA.118.313276.

Soleymanlou N., Jurisica I., Nevo O., Ietta F., Zhang X., Zamudio S., Post M., Caniggia I.: Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005;90:4299-4308. doi:10.1210/ jc.2005-0078.

Shopulotova Z., Kobilova Z., Shopulotov S. NEW OPPORTUNITIES FOR THE TREATMENT OF HYPERACTIVE BLADDER SYNDROME //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 770-773.

Shopulotova Z., Shopulotov S., Kobilova Z. MODERN VIEWS ON THE EFFECTIVENESS OF OZONE THERAPY //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 781-786.

Rakhimovna K. D., Khamzaevna K. Z. CARDIAC ARRHYTHMIAS IN PREGNANT WOMEN: A COMPREHENSIVE REVIEW //Eurasian Journal of Medical and Natural Sciences. – 2024. – Т. 5. – №. 1. – С. 35-39.

Jim B., Karumanchi S. A. Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications. Semin Nephrol. 2017;37(4):386-97. doi:10.1016/j.semnephrol.2017.

Hung T. H., Skepper J. N., Charnock-Jones D. S., Burton G. J. Hypoxiareoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res. 2002;90:1274-1281. doi: 10.1161/01. res.0000024411.22110.aa.

Chappell L. C., Cluver C. A., Kingdom J., Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341-354. doi:10.1016/S0140-6736.

Опубликован

2025-02-10

Как цитировать

THE ROLE OF BIOMARKERS AND CLINICAL AND ANAMNESTIC FACTORS IN PRE-ECLAMPSIA. (2025). Центральноазиатский журнал академических исследований, 3(2), 42-45. https://in-academy.uz/index.php/CAJAR/article/view/35198